Navigation Links
Driven by the Uptake of Several Emerging Agents, the MRSA Drug Market Will Increase From $631 Million in 2009 to $752 Million in 2019
Date:11/10/2010

poised to address the need for interchangeable IV and oral formulations.

The Pharmacor 2010 findings also reveal that the recent approval and pending launch of the broad-spectrum, first-in-class anti-MRSA cephalosporin—ceftaroline (estimated launch in January, 2011)—will change class dynamics and bring cephalosporins to the forefront of the MRSA armamentarium. Because of its broad and expanded activity against MRSA, ceftaroline is well-positioned for use as a first-line empiric therapy for suspected MRSA infections. Basilea's ceftobiprole, ceftaroline's once formidable competitor, was denied FDA approval for complicated skin and skin structure infections in December 2009 and was unable to receive European marketing authorization in February 2010. Consequently, ceftaroline will be the first and only MRSA cephalosporin on the market for the foreseeable future, given uncertainty about continued development of ceftobiprole."We believe ceftaroline will enjoy significant commercial success, earning $150 to 200 million in peak year major-market sales for MRSA infections," Dr. Vepari said.

About Pharmacor 2010The newly redesigned Pharmacor advisory service offers clients in the biopharmaceutical industry the most up-to-date information available on commercially significant disease topics.

About Decision ResourcesDecision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision
'/>"/>

SOURCE Decision Resources
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. TeleHealth Services and Reading Hospital and Medical Center Partner to Reach Technology-Driven Patient Education Goals
2. Driven by Sales of Lyrica, Cymbalta/Xeristar and Savella, the Fibromyalgia Drug Market Will Experience 4.2 Percent Annual Growth Through 2018
3. Increasing Potential for RIS-driven PACS Modules in Europe, Finds Frost & Sullivan
4. New Study Shows Meganuclease-Driven Targeted Integration Using Cellectis bioresearchs cGPS® CHO-K1 Kit to be Highly Efficient for Drug Discovery
5. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
6. Energetiq Introduces Laser-Driven Light Sources for Biophysical Applications
7. The Cancer Pain Drug Market, Driven by the Continued Dominance of Opioids, Will Increase From $2.3 Billion in 2008 to $3.7 Billion in 2018
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015
11. The Continued Uptake of Key Agents Such as Januvia, Bydureon and Byetta Will Drive The Type 2 Diabetes Drug Market to Nearly Double From $19 Billion in 2009 to $36 Billion in 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 2014 According to the ... Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, Exercise Ball), Applications ... - Global Forecast to 2019" published by MarketsandMarkets, the ... $19,786.3 Million by 2019 from $14,240.0 Million in ... to 2019. Browse 74 market data ...
(Date:9/19/2014)...  4WEB Medical announces the formal launch of the ... implants on the market today at this weekend,s ... Chicago .  The Osteotomy Truss System is ... with 74 size options included in one versatile set. ... 15 to 18 implant sizes, which limited a surgeon,s ...
(Date:9/19/2014)... , Sept. 19, 2014 Merck (NYSE: MRK ... and Canada , is teaming with celebrity ... Diabetes: Logra Tus Metas , an educational program encouraging Hispanics with ... -- a key treatment goal to help reduce the risk of ... are at a higher risk for developing type 2 diabetes ...
Breaking Medicine Technology:Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 44WEB Medical Unveils 3D-Printed Osteotomy Truss System 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... 9, 2011 Vyatta , ... and cloud infrastructures, today announced that the Vyatta ... selected to provide HIPAA compliant network security for ... information technology to deploy scalable, collaborative healthcare networks ...
... AMBLER, Pa., Aug. 9, 2011 Allergy Technologies LLC, ... liners, is sponsoring a new bed bug research program at ... by the Company. This new endeavor will ... strategies relating to innovative bed bug treatment applications. The dramatic ...
Cached Medicine Technology:Vyatta Virtual Firewall Addresses HIPAA Compliance for Thrasys 2Allergy Technologies LLC Provides Over $100,000 in a Research Grant to The Ohio State University for the Study of Bed Bugs 2
(Date:9/19/2014)... News) -- U.S. military troops deployed to sunny climates ... to a new study. Many returning troops ... some cases, military personnel developed blisters on their skin ... size of their moles since being deployed overseas. ... skin cancer, the study authors noted. "The past ...
(Date:9/19/2014)... -- Although there is mounting evidence that muscle-strength ... older adults in the United States don,t engage ... research. Less than one-quarter of adults over ... Department of Health and Human Services, the study ... health and fitness and staying independent, researchers advised. ...
(Date:9/19/2014)... The Alliance for Bangladesh Worker Safety ... Fire Protection Association (NFPA), a recognized international leader ... a Memorandum of Understanding signed by both organizations, ... stakeholders with information, guidance and access to training ... safety of workers in ready-made garment (RMG) factories ...
(Date:9/19/2014)... therapeutics using intact cells to treat and cure ... medicine but it is hindered by the inability of ... and persistence of these cells in patients without resorting ... paper published September 17 in the online journal ... of California, San Diego School of Medicine, University of ...
(Date:9/19/2014)... Tempe, Ariz. (Sept. 19, 2014) - New research published ... predicts new Ebola cases could reach 6,800 in West ... control measures are not enacted. , Arizona State ... analysis that the rate of rise in cases significantly ... time that a mass quarantine was put in place, ...
Breaking Medicine News(10 mins):Health News:Some U.S. Troops May Face Greater Skin Cancer Risk 2Health News:Adults Over 45 Not Meeting U.S. Muscle Strengthening Guidelines, Study Says 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:A better way to track emerging cell therapies using MRIs 2Health News:Research predicts possible 6,800 new Ebola cases this month 2
... misled about the dangers of taking cannabis when the Government ... a year ago, the British Home Secretary admits today. ... taken by his predecessor, David Blunkett, Charles Clarke said he ... between cannabis and mental illness. He made these damning remarks ...
... medicine was safer than western alternatives // has ... watchdog said on Wednesday. ,The leaflet could dissuade ... serious medical conditions, the Advertising Standards Authority (ASA) said. ... claimed that serious medical problems such as cancer could ...
... in less than 1 hour using a kit, based on ... sperm // samples prior to approval has 95% ... problems. This would save the valuable time lost by couples ... are advised to wait for around a year before seeking ...
... spread of the disease are clearly not working and much ... on a global basis if the disease is to be ... workers and drug addicts. ,It is here that ... both in developed and developing countries only go for HIV ...
... 2006 issue of the International Journal of Cancer says that ... them at high risk for breast cancer, could actually benefit ... A. Narod, of the University of Toronto, Ontario, and colleagues ... breast cancer in 1690 women who had either BRCA1 or ...
... amendment which states to reduce the price of the drug ... the // acting Prime Minister Mark Vaile reported ... the major opposition party in Australia (Labor Party). ... prevent the delay in the introduction of new generic drugs. ...
Cached Medicine News:Health News:UK public misled over downgrading cannabis: Govt 2Health News:Chinese medicine leaflet broke advertising code 2Health News:New Home-Fertility Kit Launched For Men 2Health News:Need of the Hour: Viable Strategies against AIDS 2